🔎 Trials Near Me

Domov › CHOPN › Texas › Houston

Klinické štúdie CHOPN v meste Houston, TX

15 štúdií pre CHOPN hľadá účastníkov v zariadeniach v meste Houston a okolí (do cca 30 míľ). Otvorte štúdiu a zistite, kto sa môže zapojiť a ako kontaktovať tím.

Oficiálny text štúdie (anglicky)

Hľadáte účastníkov do štúdie? Zvýraznite ju na začiatku tejto stránky – $99 na 30 dní →

A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease

Prebieha náborFáza 3
  • Research Site, Houston
  • Research Site, Houston
  • Research Site, Houston
Vek 40 až 80 · Všetky pohlavia · Aktualizované 2. 10. 2026 · NCT06283966

Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype

Prebieha náborFáza 3
  • Se Houston- Site Number : 8400120, Houston
  • Aavon Clinical Trials, Llc- Site Number : 8400166, Houston
Vek 40 až 80 · Všetky pohlavia · Aktualizované 1. 10. 2026 · NCT07190222

A Study of Brenipatide (LY3537031) in Adult Participants With Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD)

Prebieha náborFáza 2
  • Baylor College of Medicine Medical Center, Houston
Vek 40 až 75 · Všetky pohlavia · Aktualizované 25. 9. 2026 · NCT07759245

Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype

Prebieha náborFáza 3
  • Trio Clinical Trials- Site Number : 8400106, Houston
  • HDH Research- Site Number : 8400104, Houston
  • Baylor College of Medicine- Site Number : 8400076, Houston
  • a 2 ďalších
Vek 40 až 80 · Všetky pohlavia · Aktualizované 22. 9. 2026 · NCT07190209

A Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease

Prebieha náborFáza 2
  • Research Site, Houston
Vek 40 a viac · Všetky pohlavia · Aktualizované 9. 9. 2026 · NCT07082738

Clinical Trial of Omalizumab for Allergen Sensitized and Exposed Individuals With COPD

Prebieha náborFáza 2
  • Baylor College of Medicine, Houston
Vek 40 a viac · Všetky pohlavia · Aktualizované 4. 9. 2026 · NCT07059091

A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00007)

Prebieha náborFáza 3
  • Research Site, Houston
  • Research Site, Houston
  • Research Site, Houston
Vek 40 až 80 · Všetky pohlavia · Aktualizované 3. 9. 2026 · NCT06878261

A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00006)

Prebieha náborFáza 3
  • Research Site, Houston
  • Research Site, Houston
  • Research Site, Humble · 17 míľ odtiaľ
Vek 40 až 80 · Všetky pohlavia · Aktualizované 3. 9. 2026 · NCT06883305

A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate to Severe Chronic Obstructive Pulmonary Disease

Prebieha náborFáza 2/3
  • Greater Heights & Memorial Pulmonary and Sleep, Houston
  • Houston Pulmonary Sleep and Allergy Associates, Houston
Vek 35 až 80 · Všetky pohlavia · Aktualizované 31. 8. 2026 · NCT07363694

STRIVE Post-Market Registry Study

Prebieha náborObservačná štúdia
  • University of Texas Health Science Center at Houston, Houston
Vek 18 a viac · Všetky pohlavia · Aktualizované 3. 8. 2026 · NCT04302272

eValuating the Efficacy and Safety of InitiatinG depemokImab earLy therApy iN Chronic Obstructive Pulmonary Disorder (COPD) With Type 2 Inflammation

Prebieha náborFáza 3
  • GSK Investigational Site, Houston
  • GSK Investigational Site, Houston
  • GSK Investigational Site, Houston
Vek 40 až 75 · Všetky pohlavia · Aktualizované 28. 7. 2026 · NCT07177339

Bronchoscopic RElease of Air Trapped in Hyperinflated Emphysematous Lung - Study 3

Prebieha nábor
  • Houston Methodist/Primary Critical Care, Houston
Vek 40 až 84 · Všetky pohlavia · Aktualizované 24. 4. 2026 · NCT06891755

Depemokimab as an Extended treatmeNt Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA-2)

Prebieha náborFáza 3
  • GSK Investigational Site, Houston
Vek 40 až 80 · Všetky pohlavia · Aktualizované 9. 4. 2026 · NCT06961214

Clinical Validation of Freenome Multiomics Blood Test for Lung Cancer Screening

Prebieha náborObservačná štúdia
  • Horizon Clinical Research Group, Houston
Vek 50 a viac · Všetky pohlavia · Aktualizované 5. 8. 2025 · NCT06122077

myAirvo 3 (High Flow Nasal Therapy; HFNT) for COPD Patients in the Home

Prebieha nábor
  • Respire Research Institute, Houston
Vek 30 a viac · Všetky pohlavia · Aktualizované 6. 2. 2025 · NCT05204888

Štúdie CHOPN v iných mestách

Iné štúdie v Houston

Z ClinicalTrials.gov, dáta načítané 5. 10. 2026. Každá štúdia má vlastné kritériá oprávnenosti; tím štúdie rozhoduje o účasti.